Overview

Gender

male

Hampar has over 40 years of distinguished service in ophthalmic drug development. During his career, Hampar has brought over 30 ophthalmic drugs to market and is an author or co-author of more than 30 worldwide issued patents. Hampar is the co-founder and CEO of Allegro Ophthalmics, LLC. Previously, Hampar was the co-founder and CTO of ISTA Pharmaceuticals and served as CEO at Prima Pharmaceuticals, S K Pharmaceuticals and Vitreoretinal Technologies. He has previously raised numerous rounds of venture capital funding for several of these companies, as well as active involvement in the initial public offering of ISTA Pharmaceuticals.

Prior to co-founding Prima Pharmaceuticals, Hampar spent 23 years at Allergan Pharmaceuticals in senior management positions, including corporate head of research & development. Hampar’s extensive experience and expertise spans well beyond research and development to include drug discovery and development, domestic and international regulatory affairs, clinical studies, and API and finished product manufacturing.
- See more at: http://www.allegroeye.com/about-us/management/#sthash.bt667KEY.dpuf